Table: Fuji Pharmaceutical - 6-MTH group results

Fuji Pharma

08/05/2020 08:30

May 8 (Reuters)- 
             Fuji Pharmaceutical  Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 6 months ended      6 months ended       Year to 
                Mar 31, 2020        Mar 31, 2019     Sep 30, 2020 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             16.91               18.48            33.83    
                 (-8.5 pct)          (+2.9 pct)       (-6.8 pct)  
  Operating          1.74                2.47             2.57    
                 (-29.7 pct)         (+8.4 pct)       (-38.4 pct) 
  Recurring          1.61                2.50             2.50    
                 (-35.6 pct)         (+6.0 pct)       (-40.0 pct) 
  Net              310 mln               1.70           492 mln   
                 (-81.7 pct)         (-2.7 pct)       (-83.3 pct) 
  EPS             9.98 yen            56.66 yen        15.78 yen  
  Ann Div                             29.00 yen        29.00 yen  
  -Q2 div         14.00 yen           14.00 yen                   
  -Q4 div                             15.00 yen        15.00 yen  
  
  NOTE - Fuji Pharmaceutical  Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4554.T